Market Tracker

05/25 5:15pm ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

293.74
Delayed Data
As of May 25
 -0.87 / -0.30%
Today’s Change
281.89
Today|||52-Week Range
543.55
-21.87%
Year-to-Date

Today’s Trading

Previous close294.61
Today’s open294.12
Day’s range292.50 - 295.57
Volume637,628
Average volume (3 months)967,640
Market cap$32.8B
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)+34.29%
Earnings growth (this year)+14.65%
Earnings growth (next 5 years)+13.64%
Revenue growth (last year)+20.82%
P/E ratio23.8
Price/Sales7.42
Price/Book5.42

Competitors

 Today’s
change
Today’s
% change
SHPGShire+0.73+0.44%
VRTXVertex Pharmaceutica...+0.53+0.34%
BAXBaxter International...+0.12+0.17%
ALXNAlexion Pharmaceutic...+0.60+0.51%
Data as of 4:00pm ET, 05/25/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)$4.58
Annual revenue (last year)$5.9B
Annual profit (last year)$1.2B
Net profit margin20.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Co-President, Chief Executive Officer &
Director
Leonard S. Schleifer
Co-President, Director &
Chief Scientific Officer
George Damis Yancopoulos
Corporate headquarters
Tarrytown, New York

Forecasts